Immuneering Corporation (IMRX) Tops Q1 EPS by 5c

Immuneering Corporation (NASDAQ: IMRX) reported Q1 EPS of ($0.44), $0.05 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• JPMorgan Upgrades Nanya Technology Corp (2408:TT) to Overweight
• HSBC Downgrades Stellantis NV (STLA:IM) (STLA) to Reduce